ENGMAB SÀRL
4Patents
4Active
4Granted
45Portfolio score
Filing activity: Feb 5, 2014 → Nov 2, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9963513B2 | Method for the selection of antibodies against BCMA | Physics | 17 | Active |
| US10077315B2 | Bispecific antibodies against CD3 and BCMA | Physics | 6 | Active |
| US10683369B2 | Monoclonal antibodies against BCMA | Chemistry; Metallurgy | 4 | Active |
| US11124577B2 | Bispecific antibody against BCMA and CD3 and an immunological drug for combined use in treating multiple myeloma | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.